Andrew H. Wei
0000-0002-7514-3298
Publication & Citation Trends
Most Cited Works
Publications
828 total
Diagnosis and management of AML in adults: 2022 recommendations from an international expert panel on behalf of the ELN PDF
Cited by 2,804
OpenAlex
International Consensus Classification of Myeloid Neoplasms and Acute Leukemias: integrating morphologic, clinical, and genomic data PDF
Cited by 2,502
OpenAlex
Azacitidine and Venetoclax in Previously Untreated Acute Myeloid Leukemia PDF
Cited by 2,671
OpenAlex
Venetoclax plus LDAC for newly diagnosed AML ineligible for intensive chemotherapy: a phase 3 randomized placebo-controlled trial PDF
Cited by 735
OpenAlex
Molecular patterns of response and treatment failure after frontline venetoclax combinations in older patients with AML PDF
Cited by 636
OpenAlex
Venetoclax Combined With Low-Dose Cytarabine for Previously Untreated Patients With Acute Myeloid Leukemia: Results From a Phase Ib/II Study PDF
Cited by 694
OpenAlex
Venetoclax combined with decitabine or azacitidine in treatment-naive, elderly patients with acute myeloid leukemia PDF
Cited by 1,827
OpenAlex
Safety and preliminary efficacy of venetoclax with decitabine or azacitidine in elderly patients with previously untreated acute myeloid leukaemia: a non-randomised, open-label, phase 1b study
Cited by 701
OpenAlex
Research Topics
Acute Myeloid Leukemia Research
(477)
Ferroptosis and cancer prognosis
(159)
Cancer, Lipids, and Metabolism
(159)
RNA modifications and cancer
(147)
Chronic Myeloid Leukemia Treatments
(145)
Frequent Co-Authors
Affiliations
Goethe University Frankfurt
Poznan University of Medical Sciences
Universitat Autònoma de Barcelona
City Of Hope National Medical Center
The Royal Melbourne Hospital